Consulting with your PlexusDx provider about dose escalation, switching to tirzepatide, or completing a Precision Peptide Genetic Test can identify whether a different compound better matches your biology
Despite all the benefits, there are also very real side effects from semaglutides such as nausea, abdominal pain, bloating, diarrhea and constipation, which often go hand-in-hand with slowing down your gastrointestinal tract, and can even lead to malnutrition, Ozempic overdose and even death
When you quote exact calorie counts, exercise frequency, and duration, it becomes very difficult for anyone to suggest you simply need to try harder
They cannot claim to treat, cure, or prevent diseases, but they can make "structure/function" claims like "supports metabolism" or "promotes healthy appetite." These vague claims allow products like Peaka GLP-1 to imply pharmaceutical-level benefits without providing pharmaceutical-level evidence
Ive lost 20 pounds in 3 months, my cravings are gone, and Im back in the gym feeling confident again
Looking from 2023 to 2024, the latest year of data available, prescriptions and gross spending for Wegovy (first approved for obesity in 2021, approved for cardiovascular disease in 2024) and Mounjaro (approved for type 2 diabetes in 2022) more than doubled, and prescriptions and gross spending for Zepbound (first approved for obesity in 2023, approved for sleep apnea in 2024) increased more than fivefold
